Clinical Trial Update: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin

View source ↗

Summary

Completed retrospective chart review evaluating the antiviral supplement Gene-Eden-VIR/Novirin across multiple viral infections to assess outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Epstein-barr Virus Infection
• Herpes Simplex Virus Infection
• Human Papillomavirus Infection
• Varicella Zoster Virus Infection

Drugs mentioned

• Gene-Eden-VIR/Novirin

Snippet

Sponsor: The Center for the Biology of Chronic Disease | Conditions: Herpes Simplex Infections, Human Papillomavirus | Status: COMPLETED